Antiretroviral therapy suppressed participants with low CD4+ T-cell counts segregate according to opposite immunological phenotypes

Pérez-Santiago, Josué; Ouchi, Dan; Urrea, Victor; More

AIDS . 30(15):2275-2287, September 24, 2016.

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

Puertas, Maria C.; Massanella, Marta; Llibre, Josep M.; More

AIDS . 28(3):325-334, January 28, 2014.

HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

Carrillo, Jorge; Restrepo, Clara; Rallón, Norma I.; More

AIDS . 27(9):1375-1385, June 1, 2013.

Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery

Massanella, Marta; Negredo, Eugènia; Puig, Jordi; More

AIDS . 26(18):2285-2293, November 28, 2012.

CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART

Massanella, Marta; Negredo, Eugenia; Pérez-Álvarez, Nuria; More

AIDS . 24(7):959-968, April 24, 2010.

Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells

Massanella, Marta; Puigdomènech, Isabel; Cabrera, Cecilia; More

AIDS . 23(2):183-188, January 14, 2009.